These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 22028900)
1. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera. Wu Z; Yuan H; Zhang X; Liu W; Xu J; Zhang W; Guan M PLoS One; 2011; 6(10):e26534. PubMed ID: 22028900 [TBL] [Abstract][Full Text] [Related]
2. Melting point assay for the JAK2 V617F mutation, comparison with amplification refractory mutation system (ARMS) in diagnostic samples, and implications for daily routine. Ochsenreither S; Reinwald M; Thiel E; Burmeister T Mol Diagn Ther; 2010 Jun; 14(3):185-90. PubMed ID: 20560681 [TBL] [Abstract][Full Text] [Related]
3. A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood. Poodt J; Fijnheer R; Walsh IB; Hermans MH Hematol Oncol; 2006 Dec; 24(4):227-33. PubMed ID: 17006961 [TBL] [Abstract][Full Text] [Related]
4. Toward point-of-care testing for JAK2 V617F mutation on a microchip. Wang H; Liu W; Zhang X; Xu X; Kang Z; Li S; Wu Z; Yang Z; Yao B; Guan M J Chromatogr A; 2015 Sep; 1410():28-34. PubMed ID: 26235214 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a tetra-primer amplification refractory mutation system-polymerase chain reaction combined with melting analysis-assay for clinical JAK2 V617F mutation detection. Liu W; Hu T; Chen Y; Zhang X; Gu X; Guan M Mol Diagn Ther; 2014 Oct; 18(5):579-85. PubMed ID: 25015634 [TBL] [Abstract][Full Text] [Related]
6. Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system. Olsen RJ; Tang Z; Farkas DH; Bernard DW; Zu Y; Chang CC Arch Pathol Lab Med; 2006 Jul; 130(7):997-1003. PubMed ID: 16831057 [TBL] [Abstract][Full Text] [Related]
7. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera. Nussenzveig RH; Burjanivova T; Salama ME; Ogilvie NW; Marcinek J; Plank L; Agarwal AM; Perkins SL; Prchal JT Leuk Lymphoma; 2012 Dec; 53(12):2479-86. PubMed ID: 22642932 [TBL] [Abstract][Full Text] [Related]
8. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis. Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011 [TBL] [Abstract][Full Text] [Related]
9. Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients. Ugo V; Tondeur S; Menot ML; Bonnin N; Le Gac G; Tonetti C; Mansat-De Mas V; Lecucq L; Kiladjian JJ; Chomienne C; Dosquet C; Parquet N; Darnige L; Porneuf M; Escoffre-Barbe M; Giraudier S; Delabesse E; Cassinat B; PLoS One; 2010 Jan; 5(1):e8893. PubMed ID: 20126644 [TBL] [Abstract][Full Text] [Related]
10. A tetra-primer polymerase chain reaction approach for the detection of JAK2 V617F mutation. Koksal V; Etlik O; Arican-Baris ST; Baris I Genet Test; 2007; 11(4):463-6. PubMed ID: 18294066 [TBL] [Abstract][Full Text] [Related]
12. Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis. Jones AV; Cross NC; White HE; Green AR; Scott LM Haematologica; 2008 Oct; 93(10):1560-4. PubMed ID: 18698085 [TBL] [Abstract][Full Text] [Related]
13. Polycythemia vera is not initiated by JAK2V617F mutation. Nussenzveig RH; Swierczek SI; Jelinek J; Gaikwad A; Liu E; Verstovsek S; Prchal JF; Prchal JT Exp Hematol; 2007 Jan; 35(1):32-8. PubMed ID: 17198871 [TBL] [Abstract][Full Text] [Related]
14. Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques. Veneri D; Capuzzo E; de Matteis G; Franchini M; Baritono E; Benati M; Solero GP; Ambrosetti A; Quaresmini G; Pizzolo G Blood Transfus; 2009 Jul; 7(3):204-9. PubMed ID: 19657484 [TBL] [Abstract][Full Text] [Related]
15. Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis. Cao HC; Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF J Clin Lab Anal; 2011; 25(4):300-4. PubMed ID: 21786333 [TBL] [Abstract][Full Text] [Related]
16. Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation. Wolstencroft EC; Hanlon K; Harries LW; Standen GR; Sternberg A; Ellard S J Mol Diagn; 2007 Feb; 9(1):42-6. PubMed ID: 17251334 [TBL] [Abstract][Full Text] [Related]
17. Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique. Leszczynska A; Grzenkowicz-Wydra J; Chmielewska-Gorycka L; Bieniaszewska M; Hellmann A Acta Haematol; 2016; 136(2):123-8. PubMed ID: 27410038 [TBL] [Abstract][Full Text] [Related]
18. Methods for detecting mutations in the human JAK2 gene. Bench AJ; Baxter EJ; Green AR Methods Mol Biol; 2013; 967():115-31. PubMed ID: 23296725 [TBL] [Abstract][Full Text] [Related]
19. Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis. Sutton BC; Allen RA; Zhao ZJ; Dunn ST Cancer Biomark; 2007; 3(6):315-24. PubMed ID: 18048969 [TBL] [Abstract][Full Text] [Related]
20. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting. Lin CY; Ho CM; Tamamyan G; Yang SF; Peng CT; Chang JG J Clin Lab Anal; 2016 Nov; 30(6):838-844. PubMed ID: 27169616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]